Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Prostate Carcinoma: early-phase trial registry
31 of 60 indexed Prostate Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #235 of 28,707 conditions by registered trial count.
60 US clinical trials · 31 currently recruiting · #235 of 28,707 conditions by registered trial count
Prostate Carcinoma: 60 US clinical trials tracked, 31 recruiting.
Prostate Carcinoma is the subject of 60 registered US clinical trials on ClinicalTrials.gov, 31 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is Jonsson Comprehensive Cancer Center, running 10 of these trials.
Enrollment posture brief
Registry condition prostate-carcinoma
OPEN 31 | RECR 52% | LATE 3 | EARLY 22 | RANK #235 | SPON 10
Volume-matched condition peers
Nearest open-share peer: Cutaneous Melanoma (52% recruiting · 31 trials)
Prostate Carcinoma lists 31 open slots (52% of 60 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Prostate Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Prostate Carcinoma is recruiting above its size-band peers.
31 of 60 indexed trials (51.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Prostate Carcinoma research.
Jonsson Comprehensive Cancer Center accounts for 10 of 60 trials (16.7%). 20 distinct sponsors appear on at least one study for this condition label.
-
Typical Prostate Carcinoma enrolment sits around 96 participants.
Median target enrolment is 96 among the 60 trials that report a genuine target (sentinel values excluded). 33 of those (55%) plan for fewer than 100 participants.
-
Prostate Carcinoma research is mostly interventional.
52 interventional and 8 observational studies make up this index (86.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
60 total, page 2 of 2
Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
ECOG-ACRIN Cancer Research Group
NCT04484818
Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer
Ohio State University Comprehensive Cancer Center
NCT02722525
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
H. Lee Moffitt Cancer Center and Research Institute
NCT04879940
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
NCT04050215
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
Mayo Clinic
NCT00170157
Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy
City of Hope Medical Center
NCT03661437
Exercising Together During Radiation Treatment
OHSU Knight Cancer Institute
NCT03418025
Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
NCT04282824
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
Fred Hutchinson Cancer Center
NCT04902144
Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy
OHSU Knight Cancer Institute
NCT03135782
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 15 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Prostate Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Prostate Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Prostate Carcinoma page
60 registered trials, 31 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 31 Prostate Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jonsson Comprehensive Cancer Center sponsors the most Prostate Carcinoma trials on record, review their full trial history before evaluating a specific study. See Jonsson Comprehensive Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Prostate Carcinoma condition card totals 60 registered trials; most-linked intervention Questionnaire Administration; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.